Page last updated: 2024-08-25

rosiglitazone and Fetal Growth Retardation

rosiglitazone has been researched along with Fetal Growth Retardation in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bo, QL; Chen, YH; Fu, L; Ma, L; Song, YP; Wang, B; Wang, H; Xu, DX; Xu, S; Zhang, C1
Castillo, MO; Devaskar, SU; Oak, S; Thamotharan, M; Thamotharan, S; Tran, C1
Devaskar, SU; Garg, M; Lee, PW; Pan, G; Thamotharan, M1

Other Studies

3 other study(ies) available for rosiglitazone and Fetal Growth Retardation

ArticleYear
Lipopolysaccharide Downregulates 11β-Hydroxysteroid Dehydrogenase 2 Expression through Inhibiting Peroxisome Proliferator-Activated Receptor-γ in Placental Trophoblasts.
    Journal of immunology (Baltimore, Md. : 1950), 2019, 09-01, Volume: 203, Issue:5

    Topics: 11-beta-Hydroxysteroid Dehydrogenases; Active Transport, Cell Nucleus; Animals; Cells, Cultured; Down-Regulation; Female; Fetal Growth Retardation; Humans; Lipopolysaccharides; Male; Mice; Mice, Inbred ICR; Placenta; PPAR gamma; Pregnancy; Rosiglitazone; Transcription Factor RelA; Trophoblasts

2019
Peroxisome proliferator-activated receptor-gamma agonist improves skeletal muscle insulin signaling in the pregestational intrauterine growth-restricted rat offspring.
    American journal of physiology. Endocrinology and metabolism, 2009, Volume: 297, Issue:2

    Topics: Algorithms; Animals; Drug Evaluation, Preclinical; Female; Fetal Growth Retardation; Glucose Transporter Type 4; Growth; Hypoglycemic Agents; Insulin; Models, Biological; Muscle, Skeletal; PPAR gamma; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rosiglitazone; Signal Transduction; Thiazolidinediones

2009
Early exposure of the pregestational intrauterine and postnatal growth-restricted female offspring to a peroxisome proliferator-activated receptor-{gamma} agonist.
    American journal of physiology. Endocrinology and metabolism, 2010, Volume: 298, Issue:3

    Topics: Animals; Animals, Newborn; Blood Glucose; Body Weight; Dose-Response Relationship, Drug; Female; Fetal Growth Retardation; Humans; PPAR gamma; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones

2010